Delivered-To: tjphuhs@gmail.com Received: by 2002:adf:ec45:0:b0:435:ab39:4520 with SMTP id w5csp1381572wrn; Mon, 26 Jan 2026 15:05:27 -0800 (PST) X-Received: by 2002:a05:6a00:92a2:b0:81e:b6fb:7561 with SMTP id d2e1a72fcca58-823412f556fmr4769387b3a.70.1769468726909; Mon, 26 Jan 2026 15:05:26 -0800 (PST) ARC-Seal: i=1; a=rsa-sha256; t=1769468726; cv=none; d=google.com; s=arc-20240605; b=Bi2p25IQpLy2yRXNJ2mhHMvQpQkKXDAasA+z2tZ687u+PcbjzRhpBC/VZmjwPcadXv WP26nbmDE1w3TsUb6B+yA14VO8JkiypLQJu7OC0u1nK/5hO73s+JLDIaK+Pmh6zpO+g2 RQEi2EozyYa83woq78VL4Tk8oGrnL3fha9M6/jdHH7WyZv6xizlyg6nSqm+BCyHupW+q 8vTjasr7sQSUIjxTbxq2wPP+SXt5CQ2gvlb8YNXBhwZu9VC6KDLloCprNIx+m5UgE2c3 VIN7frGV9jDmzGrIlkp4t9xnuWz1lpXe1YXLKeOEJYfQJxMNSIXS2TRe/mqOgvo1s60s E9Zg== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605; h=to:subject:message-id:mime-version:from:date:dkim-signature :dkim-signature; bh=R7VrNnxR5vBPZ/+igSAoecpqjndv2CEoYTK1YR2FbDE=; fh=HRf6yyghNOjQDshkl9V8M2R5zVUW8nIXxjp8HF/gBco=; b=RnoFmFDUDiiTlXzRbeA0pKo0YMhhNGJV5IsIHtS2zN8JWNL6g+LQpQRO/Vix+FeqlA 48iTLt7Vdr95nzkQz1DJq0wJ7+TgzSYGKMS0mzm/3tvLl0ZBKfmAZ88fbF75O0vt5PGC 0QFKuv03U6eY5kKjORTZUwaDz9QqVNjpk9qeeqCjXEmZeq7FU/XYZcjMJ0J/0uYYxtbc av1oAnRpULEL/XxQt7whn+Eo6+g9y98qa0TBRIagEIacKPuyY9oS3ja9kT8zwc/N0sDM fGBpNOmN8cDs2L6duyUTNNVytAaTqiScdf0BVWY97p+tII8RbOUYckRvxN/0WSOBMFLD JlKA==; dara=google.com ARC-Authentication-Results: i=1; mx.google.com; dkim=pass header.i=@skool.com header.s=m1 header.b=NwTTgh1f; dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=m2p5JinN; spf=pass (google.com: domain of bounces+51791150-dbea-tjphuhs=gmail.com@mail.skool.com designates 159.183.19.226 as permitted sender) smtp.mailfrom="bounces+51791150-dbea-tjphuhs=gmail.com@mail.skool.com"; dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=skool.com Return-Path: Received: from o2.ptr677.skool.com (o2.ptr677.skool.com. [159.183.19.226]) by mx.google.com with ESMTPS id d2e1a72fcca58-8231871a27fsi17901052b3a.198.2026.01.26.15.05.26 for (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128); Mon, 26 Jan 2026 15:05:26 -0800 (PST) Received-SPF: pass (google.com: domain of bounces+51791150-dbea-tjphuhs=gmail.com@mail.skool.com designates 159.183.19.226 as permitted sender) client-ip=159.183.19.226; Authentication-Results: mx.google.com; dkim=pass header.i=@skool.com header.s=m1 header.b=NwTTgh1f; dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=m2p5JinN; spf=pass (google.com: domain of bounces+51791150-dbea-tjphuhs=gmail.com@mail.skool.com designates 159.183.19.226 as permitted sender) smtp.mailfrom="bounces+51791150-dbea-tjphuhs=gmail.com@mail.skool.com"; dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=skool.com DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=skool.com; h=content-type:date:from:mime-version:subject:to:cc:content-type:date: feedback-id:from:subject:to; s=m1; bh=R7VrNnxR5vBPZ/+igSAoecpqjndv2CEoYTK1YR2FbDE=; b=NwTTgh1fgnr0giLGUE0z4QauZaZv+HTk3em2e+5p64pm3kydcFK76i2VSW0mdgj0/rZN N6ghWPgRfUq87KDS5eXDkXdIEuZrowodGmONUNsF1yM7NFDRBA9PoLUpMQrpM8xacUEbY7 qhLJxFnsh1jLwcPDP36nFAInZTK8nybm8= DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=sendgrid.info; h=content-type:date:from:mime-version:subject:to:cc:content-type:date: feedback-id:from:subject:to; s=smtpapi; bh=R7VrNnxR5vBPZ/+igSAoecpqjndv2CEoYTK1YR2FbDE=; b=m2p5JinNQa4ZC+3LRJ+/Y15QXqNeMbJZJOSBcX+lMGcyrzQEYpmbLfyY++kNtdxM/PUd FnX69e8f3I/KNR3mJWyEI97zAkndKKXpH9SToaI8TXlegOBfK0yydEQjC4lFn5cJ2CUK2P p7FwYiEkmzjFDakt7c1OXFdT6FnnorJ2M= Received: by recvd-77c97b74bf-fh6l5 with SMTP id recvd-77c97b74bf-fh6l5-1-6977F335-D2 2026-01-26 23:05:25.865026998 +0000 UTC m=+3459289.003548675 Received: from NTE3OTExNTA (unknown) by geopod-ismtpd-14 (SG) with HTTP id NewmrltWTwWNRTBF1AIM3Q Mon, 26 Jan 2026 23:05:25.843 +0000 (UTC) Content-Type: multipart/alternative; boundary=cd47accdb1c8fedd5f674443c26a600fb43ebad8fb2574e2ef659d89c786 Date: Mon, 26 Jan 2026 23:05:25 +0000 (UTC) From: "Peptide Research Forum (Skool)" Mime-Version: 1.0 Message-ID: Subject: 12 new notifications since 6:05 pm (Jan 25, 2026) X-SG-EID: =?us-ascii?Q?u001=2EubHp4JcR5c901DNKInUyPm7dF=2FCf7fvbvoo6xAmK=2Fk3zuItGn=2FgZbslI6?= =?us-ascii?Q?dj8O0MuTGOgjtZrhg72gRCz8gNM6s71ivCV5KCc?= =?us-ascii?Q?hyUI7=2Fpb684QJ8jQjUYScCpTJoJdRx0w90gcVBA?= =?us-ascii?Q?tqmYgybVk5s9jPFVePGn1gO0qBQzita7i6QqLGy?= =?us-ascii?Q?T++Cdd8wICF8LTysVC=2FxPektH12K7wR4cMDsoEQ?= =?us-ascii?Q?ZXzPb85OF616l2esAU=2FTqM0QitIgzc=2Fb1RsJcz1?= =?us-ascii?Q?8w2z?= X-SG-ID: =?us-ascii?Q?u001=2ESdBcvi+Evd=2FbQef8eZF3Bn0=2F1wqYKdPmI+SecjXfzkexw5XZq85qJVoOl?= =?us-ascii?Q?n8C3YWz=2F2mp6FhFOiIkITN0GVhde7dPQ8Z8hEPo?= =?us-ascii?Q?I2jl3YP8PCHNYBlDWpw9mo9McELO=2Fv1QNf3bVqU?= =?us-ascii?Q?vzE2xtGEjYes2b8HllDa92T8GD3ghVnEpVblgZV?= =?us-ascii?Q?Fjy6tDXydR4vfxY2gmb+wRK7aHI1wRjdGQ2Vg0g?= =?us-ascii?Q?vg4RpAGQRmrrgiNnpv=2FbvqaYhzlH54YhmVI+18U?= =?us-ascii?Q?gRiHGSm5B9jpC=2F4z=2FZ10fsWC2esWiPhUIvt7IWZ?= =?us-ascii?Q?705RkEtNYV2zDG0TK97hs7Zmi3hesQpxaOt8BLy?= =?us-ascii?Q?ml=2F8rk0Ky3lw=3D=3D?= To: Tj B X-Entity-ID: u001.YyfUs6GcaMiTWcD8cP6Peg== --cd47accdb1c8fedd5f674443c26a600fb43ebad8fb2574e2ef659d89c786 Content-Transfer-Encoding: quoted-printable Content-Type: text/plain; charset=utf-8 Mime-Version: 1.0 Peptide Research Forum ( https://link.skool.com/ls/click?upn=3Du001.wK6x93jhdVos-2F3TofGJCJqYIach7= -2FtMhH3n-2Fh9qG9l0GnWL4PQOS-2FZ5VkS4LpRux6cLnt8iwWzMy60vV13NsmSkVAqQ6xINO8= 4lL5vgJGcj25AcC730epr-2BJNkMe2b11hUGBGOEDRjk0X9uh69usMpBfU47CevKCj2xPbbrrAQ= bVlKyWmpBwUC5bK4S5yQnUp-2Bn7ZVR9P0XvxtrxvYbnxS12vq4bPvD9aAV4Fhfh1iBI-2B1TBx= 2dtzuTT4gPjAa403Hxm_Rp1oF-2B94kLqdQYeiHZJJNy7edAs5e4zrNVm36Mi3FeCFXPl9pgXHZ= bouoZDfMirbOI2brAPXEThZSqVtO-2FS-2F7PFzF1rgMtlQ3UQmqvcd6QYaXj4e2LqPh4t0rwey= khEqDL40XQfdcUuUXQkWdWEqKJFeyFHeBe1LQZhXLvF1LTRPPc5uStc1U40oA5nEyvBl12RqmMb= EzB6URmhuGP-2FSTD2uKc53dBOEJLcOVnfIEvgvlurDtcpDU-2FlS8Qs1m2SV4irqjN1eICfSLb= je0duzOnK5KxVhSVtLYm-2F7xfU6G61WhyomjzElGu6I-2B2eZfAjAdQWOIEFyEjb8kPGQmdXwA= b2mWeNVMBerc18fQxzangWLMJldQdWVzteXx-2BybdOOwdYnr5jexe6aiaruDv7OfN1GxqcH1qd= xd3BdABJzBlf9NJwr8rCC7Yxk9z84DgAmKYGQptC6-2B83kzxCGiHGR6UUFpV9qTLdfRu-2Bnxp= cUn5VBdE8sjHiIRV7ReRpw8PBG69UQDLAnWInNxk0NF-2FjNqQg-3D-3D ) ************************* 12 new notifications ************************* Since 6:05 pm (Jan 25, 2026) Here's a summary (10 of 12) of what you missed:=20 =20 =20 CA =20 ( ) ( ) =20 PR =20 ( ) ( ) View Group ( https://link.skool.com/ls/click?upn=3Du001.wK6x93jhdVos-2F3TofGJCJpQRf55z= hr7DNm-2FR-2BmY-2BDj9GgSvbCQayKKmJXcqFElFErDpKFgfmxhqq-2BQH7PKNNLw-3D-3Dh2A= 3_Rp1oF-2B94kLqdQYeiHZJJNy7edAs5e4zrNVm36Mi3FeCFXPl9pgXHZbouoZDfMirbOI2brAP= XEThZSqVtO-2FS-2F7PFzF1rgMtlQ3UQmqvcd6QYaXj4e2LqPh4t0rweykhEqDL40XQfdcUuUXQ= kWdWEqKJFeyFHeBe1LQZhXLvF1LTRPPc5uStc1U40oA5nEyvBl12RqmMbEzB6URmhuGP-2FSTD2= uKc53dBOEJLcOVnfIEvgvlurDtcpDU-2FlS8Qs1m2SV4irqjN1eICfSLbje0duzOnK5KxVhSVtL= Ym-2F7xfU6G61WhyomjzElGu6I-2B2eZfAjAdQWOIEFyEjb8kPGQmdXwAQPy-2BzwySKAzSpEAi= ojKLE7ClVFuWMKDgg6Y4hZ2PZepmpsRrAIGxwXQGAPYHlcHziyeE7igUF1C0uTODEUl1ddOZU-2= F5VJR8KDik6EtnDP9bl90aoBJoHpgFI5ZyaXA1k4ICm8khC6d8Iyo1oi6NwAWLeFhhxI6lLLthi= rggI99-2Bj4YrcZLqdF8cAceBNGJS7w-3D-3D ) Are we sending you too many emails? We=E2=80=99re bundling up all your email notifications: Daily Change to: Hourly ( https://link.skool.com/ls/click?upn=3Du001.wK6x93jhdV= os-2F3TofGJCJv2x-2FXYKi-2F266Yv7HF2lGr2lKEDUFdUmJbSqgmJ4GHGXwdeLAhi0ttQVU-2= BJn-2FSc7eLHj-2FjQ57b6DwiDwnULkhHGGM5nTBuwdENAEYeRWG40Jba3CElDV2vcKLX2IjWsL= 61NPA7YVvJ-2BV7lLeKjugkQtBEIrQ1SN83tPWnhWTsgiQaHXFWmoL-2B0X0YkcYWwv42orXFsL= MSURkRx34JKNcJps-3DDh1w_Rp1oF-2B94kLqdQYeiHZJJNy7edAs5e4zrNVm36Mi3FeCFXPl9p= gXHZbouoZDfMirbOI2brAPXEThZSqVtO-2FS-2F7PFzF1rgMtlQ3UQmqvcd6QYaXj4e2LqPh4t0= rweykhEqDL40XQfdcUuUXQkWdWEqKJFeyFHeBe1LQZhXLvF1LTRPPc5uStc1U40oA5nEyvBl12R= qmMbEzB6URmhuGP-2FSTD2uKc53dBOEJLcOVnfIEvgvlurDtcpDU-2FlS8Qs1m2SV4irqjN1eIC= fSLbje0duzOnK5KxVhSVtLYm-2F7xfU6G61WhyomjzElGu6I-2B2eZfAjAdQWOIEFyEjb8kPGQm= dXwAQTYo6rc-2BQTa0NORk-2BF52RJl2o-2FeV5uesjmORWUOS-2B8d2TmKxQ3wxxT9hMToZ1ku= 1Ht7owwHcMNVGtMUa8gDQnCtF8pJiSrHlxyhB3PnCi44D-2BTzgyDz8bE-2Fpn3et-2FWgS6esr= gKWIDTbDK1U7zSYhAKxIqTrzDFqCssiynmFCwFCbpMxuGQb9uIjOZ-2BSBWTbrQ-3D-3D ) = =E2=80=A2 Weekly ( https://link.skool.com/ls/click?upn=3Du001.wK6x93jhdVos= -2F3TofGJCJv2x-2FXYKi-2F266Yv7HF2lGr2lKEDUFdUmJbSqgmJ4GHGXwdeLAhi0ttQVU-2BJ= n-2FSc7eLHj-2FjQ57b6DwiDwnULkhHGGM5nTBuwdENAEYeRWG40Jba3CElDV2vcKLX2IjWsL61= NPA7YVvJ-2BV7lLeKjugkQtBEIrQ1SN83tPWnhWTsgiQaHXFWmoL-2B0X0YkcYWwv42jsfaZYpb= UK5qhZg8s-2BpMpU-3DuypM_Rp1oF-2B94kLqdQYeiHZJJNy7edAs5e4zrNVm36Mi3FeCFXPl9p= gXHZbouoZDfMirbOI2brAPXEThZSqVtO-2FS-2F7PFzF1rgMtlQ3UQmqvcd6QYaXj4e2LqPh4t0= rweykhEqDL40XQfdcUuUXQkWdWEqKJFeyFHeBe1LQZhXLvF1LTRPPc5uStc1U40oA5nEyvBl12R= qmMbEzB6URmhuGP-2FSTD2uKc53dBOEJLcOVnfIEvgvlurDtcpDU-2FlS8Qs1m2SV4irqjN1eIC= fSLbje0duzOnK5KxVhSVtLYm-2F7xfU6G61WhyomjzElGu6I-2B2eZfAjAdQWOIEFyEjb8kPGQm= dXwAUIE7JacEg3uACCKbB2nsU2XIgBTjQL5uiK-2BTeufpr-2Fnf23nUd3W3dPEQH07qnCpqoIW= VeiBWs9Md4pjLNffULG0JHvAAw7frO7KZHtCCuD0hnmyzR7qlz-2F1Y1PnVnIokDnI3g874UK5J= t08D-2FTzwqQIT6nW4Zq3cUQZSgKbfUxeNK84ByzujeKHpJWgsyMZdQ-3D-3D )=20 Change notification settings ( https://link.skool.com/ls/click?upn=3Du001.w= K6x93jhdVos-2F3TofGJCJqYIach7-2FtMhH3n-2Fh9qG9l1PI-2Fm-2BraVkdOOdLOhb-2F-2B= 9kC6CS8L3GE-2B2twtfU-2FANqqw-3D-3DD4T3_Rp1oF-2B94kLqdQYeiHZJJNy7edAs5e4zrNV= m36Mi3FeCFXPl9pgXHZbouoZDfMirbOI2brAPXEThZSqVtO-2FS-2F7PFzF1rgMtlQ3UQmqvcd6= QYaXj4e2LqPh4t0rweykhEqDL40XQfdcUuUXQkWdWEqKJFeyFHeBe1LQZhXLvF1LTRPPc5uStc1= U40oA5nEyvBl12RqmMbEzB6URmhuGP-2FSTD2uKc53dBOEJLcOVnfIEvgvlurDtcpDU-2FlS8Qs= 1m2SV4irqjN1eICfSLbje0duzOnK5KxVhSVtLYm-2F7xfU6G61WhyomjzElGu6I-2B2eZfAjAdQ= WOIEFyEjb8kPGQmdXwAZodmU44TfrsmHPEbfJChG7Hc9XLe6UiuKezxXh5YYPqXULsSBZjynU8-= 2BRQ-2Fwn9LtWJOrkD6FWfmpKzaPZJs1eHxLJaoKYPLlIp7opfN4gBqg18x80RFUwJoXdhAZ65-= 2Bf7mZEX71B8FxDm0JjLAkAUeMfux6yLU7KcxCfqAkM4Ad3e1V9dV-2Fzii1przY-2Fq9cSA-3D= -3D ) Start your own s k o o l ( https://link.skool.com/ls/click?upn=3Du001.wK6x9= 3jhdVos-2F3TofGJCJqYIach7-2FtMhH3n-2Fh9qG9l0GnWL4PQOS-2FZ5VkS4LpRux6cLnt8iw= WzMy60vV13NsmSkVAqQ6xINO84lL5vgJGcj25AcC730epr-2BJNkMe2b11hUGBGOEDRjk0X9uh6= 9usMpBfU47CevKCj2xPbbrrAQbVlKyWmpBwUC5bK4S5yQnUp-2Bn7ZVR9P0XvxtrxvYbnxS12vq= 4bPvD9aAV4Fhfh1iBI-2B1TBx2dtzuTT4gPjAa403vrN_Rp1oF-2B94kLqdQYeiHZJJNy7edAs5= e4zrNVm36Mi3FeCFXPl9pgXHZbouoZDfMirbOI2brAPXEThZSqVtO-2FS-2F7PFzF1rgMtlQ3UQ= mqvcd6QYaXj4e2LqPh4t0rweykhEqDL40XQfdcUuUXQkWdWEqKJFeyFHeBe1LQZhXLvF1LTRPPc= 5uStc1U40oA5nEyvBl12RqmMbEzB6URmhuGP-2FSTD2uKc53dBOEJLcOVnfIEvgvlurDtcpDU-2= FlS8Qs1m2SV4irqjN1eICfSLbje0duzOnK5KxVhSVtLYm-2F7xfU6G61WhyomjzElGu6I-2B2eZ= fAjAdQWOIEFyEjb8kPGQmdXwATrIyQsK6xhYl3Dg1uQolQyzMAtL4Zw78xb6D7NLT2cDc-2BMs-= 2B3R2K16IGUiUx-2BGA1RGPgTxMXTRroVx9ceRx5D706-2B-2FGHnikveOsqZjbDVZa78tBAp7i= uRlwfrvtDSrtCVV-2BVglU45uhYVQ-2FydNaGH82QPvhsl22fbbX7rMI5chkluVFhZQyD6ynPQY= n3oDr9A-3D-3D ) --cd47accdb1c8fedd5f674443c26a600fb43ebad8fb2574e2ef659d89c786 Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset=utf-8 Mime-Version: 1.0
3D"group
Peptide Research Forum
3D"skool

12 new notifications

Since 6:05 pm (Jan 25, 2026)
Here's a summary (10 of 12) of what you mi= ssed:=20
=20 =20
3D"user
Dani Phae (following) posted:
Heeeeelp!!! =F0=9F=98=A9 <= /span >
I need to shovel my driveway so that,= hopefully, the level 3 restriction is downgraded to a level 2 by tomorrow<= img height=3D"0" width=3D"0"/>. That way I can back my car out of the garag= e and drop the packages off at the post office.
View post
3D"user
Dani Phae (following) posted:
Coupon
=E2=9D=84=EF=B8=8F SNOW DAY SALE IS L= IVE =E2=9D=84=EF=B8=8F Since we=E2=80=99re snowed in=E2=80=A6 let=E2=80=99s make it a deal day =F0= =9F=98=8C For a limited time: =F0=9F=A7=AA Spend $300 or more on peptides =E2=86=92 Get $50 OFF your bask= et Coupon code: SNOWDAY Important details: =E2=80=A2 Minimum purchase: $300 =E2=80=A2 Applies to peptides only =E2=80=A2 Does not apply to SS-31 (because it=E2=80=99s not l...=20 Read more
View post
3D"user
Dani Phae (following) posted:
Cagri Dosage Protocol
Cagrilintide =E2=80=94 Clinical Trial= Dosage & Protocol Injection type: Subcutaneous Frequency: Once weekly (same day each week) Option 1 =E2=80=94 Fixed weekly doses studied (cagrilintide alone) These were the once-weekly dose levels used in the phase 2 dose-finding tri= al: - 300 mcg weekly (0.3 mg) - 600 mcg w...=20 Read more
View post
3D"user
Dani Phae (following) posted:
Reta Dosage Protocol
=E2=AD=90 Retatrutide (Reta) =E2=80= =94 Clinical Trial Dosage Protocol =E2=AD=90 Injection type: Subcutaneous Frequency: Once weekly (same day each week) Option 1 =E2=80=94 Low dose (no titration) - 1 mg weekly Option 2 =E2=80=94 Target: 4 mg weekly Method A (gradual): - Weeks 1=E2=80=934: 2 mg weekly - Week 5+: 4 mg weekly Method B (direct...=20 Read more
View post
3D"user
Dani Phae (following) posted:
Giveaway Time!!
=F0=9F=8E=89 SS-31 GIVEAWAY =E2=80=93= 1st & 2nd PRIZE =F0=9F=8E=89 I=E2=80=99m doing a giveaway for those who are genuinely interested in tryi= ng SS-31 (or already cycling it and plan to use it). This isn=E2=80=99t for curiosity collectors =F0=9F=98=84 =E2=80=94 I want t= his to go to someone who will actually use it and benefit from it, not let = it sit around coll...=20 Read more
View post
3D"user
Dani Phae (following) posted:
My Opinion on SS-31
Why I Believe SS-31 Should Be One of = the First Peptides Most People Consider (Outside of GLP-1s) When people first step into the peptide world, I=E2=80=99ve noticed somethi= ng interesting: Their first peptides are almost always BPC-157, GHK-Cu, or something simila= r. And don=E2=80=99t get me wrong =E2=80=94 those are grea...=20 Read more
View post
3D"user
Dani Phae (following) posted:
The Downside of Cycling To= o Many Peptides at Once
The Downside of Cycling Too Many Pept= ides at Once In the peptide world, it=E2=80=99s easy to fall into the mindset of: =E2=80=9CIf one peptide is good, five must be amazing.=E2=80=9D But the body doesn=E2=80=99t work that way. Stacking too many peptides at once can reduce effectiveness, increase side = effects, confuse results, ...=20 Read more
View post
3D"user
Dani Phae (following) posted:
Peptide Research Bloodwork= Guide
=F0=9F=A7=AC Peptide Research Bloodwo= rk Guide What to test BEFORE, DURING, and AFTER =E2=80=93 plus peptide-specific labs =E2=9C=85 PART 1 =E2=80=94 UNIVERSAL BASELINE LAB CHECKLIST (Everyone should get this before starting any peptide) Core Health & Safety =E2=98=90 CBC =E2=98=90 CMP (AST, ALT, ALP, bilirubin, creatinine, electrolytes) =E2=98=90 Lipid...=20 Read more
View post
3D"user
Dani Phae (following) posted:
Triptorelin
Triptorelin (GnRH Agonist): The =E2=80=9CMaster Switch=E2=80=9D of the HPG Axis = =E2=80=94 FDA-Approved, Clinically Powerful, and Widely Studied Triptorelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist th= at acts at the very top of the reproductive hormone cascade (hypothalamus = =E2=86=92 pituitary =E2=86=92 gonads). Becau= se...=20 Read more
View post
3D"user
Dani Phae (following) posted:
Microneedling with Glutath= ione, GHK-CU & SNAP-8
Microneedling with Lyophilized Glutat= hione + Raw GHK-Cu + SNAP-8: A Complete Safe= ty & Usage Guide Microneedling significantly increases skin permeability, allowing certain p= eptides and antioxidants to reach deeper layers of the epidermis. When done correctly, combining lyophilized glutathion= e, raw ...=20 Read more
View post
Are we sending you too many emails?
We=E2=80=99re bundling up all your email notifi= cations: Daily

Change to: Hourly =20 =E2=80=A2 Weekly

Start your own skool
3D"" --cd47accdb1c8fedd5f674443c26a600fb43ebad8fb2574e2ef659d89c786--